Navigation Links
Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013
Date:2/14/2013

Non GAAP measure) at December 31, 2012 was $373 million (December 31, 2011: Non GAAP net debt of $488 million) including the impact of share purchases totalling $106 million under the share buy-back program.

  1. LDX, currently marketed as VYVANSE in the US and ELVANSE in certain territories in the EU for the treatment of ADHD.


OUTLOOK


We enter 2013 in a good position following our strong performance in 2012 and the investments we have made in previous years. We anticipate that our highly differentiated portfolio will deliver product sales growth in the low double digits.

We note the recent news of the approval of Barr's ANDA for ADDERALL XR. We derive insignificant income from our authorised generic supply contract with Barr (now owned by TEVA). We believe that branded ADDERALL XR can continue to compete successfully in a generic market as it has done over the last four years.

Royalties and other revenues are expected to be 30-40% lower than 2012. This reflects a full year's impact of the lower ADDERALL XR authorized generic royalty rate receivable from Impax, along with generic competition and patent expiry on other products, and the one-time $38 million of royalty income recorded in Q4 2012 following the resolution of the disagreement with GSK.

Our Non GAAP gross margin is expected to be at a similar level to 2012.

We expect high single digit growth in combined Non GAAP R&D and SG&A costs, with growth significantly weighted towards Non GAAP R&D as we continue to invest in our promising pipeline and progress our late stage clinical trials.

Our core effective tax rate on Non GAAP income is anticipated to remain in the range of 18-20%.

As we look forward to the year ahead, we expect our financial results to show further growth in line with current consensus earnings expectations for 2013(1).

  1. Based on the most recent consensus estimates
    '/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
2. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
3. Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
4. Dr Steven Gillis to Join Shire Board of Directors
5. Shire Second Quarter Product Sales Up 16%
6. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
7. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
8. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
9. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
10. Study Delivers Investment Benchmarks across Key New Product Launch Activities in Pharmaceutical Sector
11. SIS Delivers Advanced Interoperability With Siemens Soarian Clinicals To Improve Efficiency, Communication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Northstar Global Business Services, Inc. (OTCPink:MDIN) today ... made their final decision and has determined to ... effective December 15, 2014, and has resumed accepting ... book entry transfer services. All deposit restrictions have been ... fully "DTC Eligible", and has resumed electronic trading ...
(Date:12/17/2014)... , The new Dompé website ... concerning the biopharmaceutical Group,s national and international clinical research activities ... recently launched institutional website that is receiving accolades from all ... new chapter in the fascinating story of Drug Discovery   ... hub on the world of clinical research, ranging from information ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today announced completion of enrollment in its first Phase ... 3-month observations confirmed the 1-month findings that were ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... a Generation 2.5 antisense drug designed to treat cancer.  ... activator of transcription 3 (STAT3). Because STAT3 is over ... potential to be broadly useful for both solid and ...
... 2012 The Board of Conformetrix Ltd, ... appointed Dr Sam Williams as Chief Executive Officer, it ... and business development expertise, was previously a Non-Executive Director ... Conformetrix,s founder scientists, Dr Andrew Almond, who becomes Chief ...
Cached Medicine Technology:Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx 2Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx 3Isis Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx 4Conformetrix Appoints Dr Sam Williams as Chief Executive Officer 2
(Date:12/22/2014)... 22, 2014 Luxury Linen purveyor Peacock ... of Dallas to provide logistics and support for one ... Alley has a long history of giving back to the ... of this year's Toy Drive were Whataburger® and 99.5 The ... than the holidays. Providing gifts to children who would otherwise ...
(Date:12/22/2014)... Ill. (PRWEB) December 21, 2014 ... recommendations for chest computed tomography (CT) to evaluate ... relevant findings, including cancer, according to a new ... , Researchers said the findings show that radiologist ... represent valuable contributions to patient care. , RAIs, ...
(Date:12/21/2014)... 22, 2014 In this report, ... by power source, product, and application. The market, ... and pneumatic instruments. By product, the market covers ... segments. The handpieces market is further subdivided into ... coagulators, laparoscopic instruments, shavers, wire/pin drivers, and others. ...
(Date:12/21/2014)... December 21, 2014 Khanna Vision Institute ... guest at the Aspen Helicopters holiday event for underprivileged ... Santa with sleigh, flown by an aspen helicopter pilot. ... only Santa with sleigh was visible.(please see accompanying video). ... night. Dr.Khanna has helped many pilots with Pi in ...
(Date:12/21/2014)... Dennis Thompson HealthDay Reporter ... tobacco smokers find e-cigarettes less addictive than traditional cigarettes, new ... often as they did regular cigarettes, thousands of ex-smokers said ... impulsive and irritable over their need to smoke, researchers reported. ... score was significantly less for e-cig use than for tobacco ...
Breaking Medicine News(10 mins):Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3
... Do,Lunch, Inc. is bringing women with alopecia areata ... different from a traditional,support group, the non-profit,s dining ... public awareness. Founder and president,Thea Chassin, bald for ... the,country. According to Chassin, "Our congenial approach is ...
... Brochure as Key Patient Resource on Restorative Options, ... Dental,Association (PDA) is recommending that PDA member dentists ... Association (ADA) when discussing,restorative options with patients., ... give,patients the latest information on oral health issues," ...
... A new study shows that exposure to a chemical ... be harmful to the nose and airways of mice. ... (NIEHS), part of the National Institutes of Health, conducted ... obliterative bronchiolitis (OB) in humans. OB is a debilitating ...
... Surgery is the only curative treatment in patients ... concept a reliable diagnostic procedure is of great ... growth along the bile duct, imaging techniques including ... of limited sensitivity for the detection of bile ...
... Society invites medical and science reporters to attend a special ... learn whats new in the fight against cancer and hear ... Society. This informative media briefing will offer the latest trends ... research, prevention, early detection, patient services, and more. , The ...
... consumption increases the risk of ESCC. There are synergetic ... The risk of ESCC in moderate-to-heavy drinkers, ALDH2 (1/2) ... with the CYP2E1 (c1/c1) genotype; leads to synergetic interactions, ... + 2/2); ALDH2 (1/1) + CYP2E1 (c1/c2 + c2/c2). ...
Cached Medicine News:Health News:In Northern California Bald Women Get Their Heads Together 2Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2Health News:Rodent study finds artificial butter chemical harmful to lungs 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 2Health News:American Cancer Society science reporters briefing to feature latest developments in cancer 3Health News:Alcohol consumption and polymorphisms of cytochromes P4502E1 are high risks for ESCC 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: